Conversely, negative immunoreactivity for SUFU was present in 19.57% of ccRCC tissues, low in 54.34%, moderate in 26.09%, and no high immunoreactivity for SUFU, illustrating a decrease of SUFU expression in cancerous tissues. This evidence concerns the gene SUFU and nonpapillary renal cell carcinoma.